Skip to content

Effect of Maxillary Nerve Block for Septoplasty

Effect of Maxillary Nerve Block for Septoplasty

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06417723
Enrollment
60
Registered
2024-05-16
Start date
2024-06-01
Completion date
2024-09-15
Last updated
2024-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Pain

Keywords

postoperative pain, maxillary nerve block, septoplasty

Brief summary

The aim of this study was to determine the effect of maxillary nerve blockage on both postoperative pain scores and recovery quality index in septoplasty operations. Thus, it was aimed to determine an alternative method that can be used in postoperative analgesia that will suppress postoperative pain complaints and increase the comfort level of patients after septoplasty operations.

Detailed description

Patients who were planned to be operated for septoplasty at Adıyaman University Training and Research Hospital, who were informed about the study and agreed to participate in the study with their written consent were included in the study. The patients who agreed to participate in the study were divided into two groups by closed envelope method and bilateral maxillary nerve blockade was planned to be performed using 10 cc 0.25% bupivacaine via suprazigomatic approach after providing airway safety in the block group with general anaesthesia applications in both groups. The haemodynamic values (blood pressure arterial, peak heart rate, peripheral oxygen saturation), postoperative numeric pain scores and postoperative quality of recovery index (QoR-15) values at the 24th hour were recorded and these values were compared in both groups. Thus, it was aimed to evaluate the effects of maxillary nerve blockade in septoplasty operations.

Interventions

It is aimed to reach the maxillary nerve trace with a peripheral nerve block needle using the suprazigomatic approach and to create a temporary block in the maxillary nerve with local anaesthetic injection.

Sponsors

Adiyaman University Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

for patients - closed envelope system for investigator - Maxillary nerve block performer will not participate pain and results assesment

Intervention model description

two groups designed from septoplasty patintes for study. 1. only general anesthesia 2. General anesthesia + maxillary nerve block

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* ASA I-II , Septoplasty patints

Exclusion criteria

* ASA III-IV * Deny to participte in study

Design outcomes

Primary

MeasureTime frameDescription
The visual analog pain scorethree monthsThe visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between no pain and worst pain.

Secondary

MeasureTime frameDescription
Quality of recovery (QoR -15)three monthsThe QoR-15 scale is a unidimensional measurement of quality of recovery measured in five domains: physical comfort, pain, physical independence, psychological support, and emotional state. The QoR-15 scale provides a score ranging from 0 to 150, with a high score indicating a good quality of recovery

Countries

Turkey (Türkiye)

Contacts

Primary ContactNezir Yılmaz
yilmaznezirr@gmail.com05068939496

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026